Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
55 studies found for:    Open Studies | "Muscular Dystrophy, Duchenne"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention:
2 Recruiting Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Magnetic Resonance Imaging (MRI);   Other: Pulmonary Function Testing (PFT);   Other: Metabolic Exercise Testing using stationary bicycle;   Other: Echocardiogram
3 Recruiting Rimeporide in Patients With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Rimeporide
4 Not yet recruiting An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Biological: PF-06252616
5 Recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: PF-06252616;   Drug: Placebo
6 Recruiting An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/day/day;   Drug: Vamorolone 0.75 mg/day/day;   Drug: Vamorolone 2.0 mg/day/day;   Drug: Vamorolone 6.0 mg/day/day
7 Recruiting A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Vamorolone 0.25 mg/kg/day;   Drug: Vamorolone 0.75 mg/kg/day;   Drug: Vamorolone 2.0 mg/kg/day;   Drug: Vamorolone 6.0 mg/kg/day
8 Recruiting Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: DS-5141b
9 Not yet recruiting Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Device: Acquisition on TouchScreen;   Device: Acquisition on Kinect;   Device: Acquisition on LeapMotion
10 Recruiting Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping
Condition: Duchenne Muscular Dystrophy
Intervention:
11 Recruiting Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: (+)- Epicatechin
12 Recruiting Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Translarna
13 Recruiting Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Prednisolone
14 Not yet recruiting Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Cardiac MRI with contrast;   Other: Cardiac MRI without contrast;   Other: Blood Test;   Other: Heart Rate;   Other: Pulmonary Function Test;   Other: Genetic Testing;   Other: Repeat MRI scan
15 Recruiting Strength Training in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Procedure: Aim 2 Exercise group;   Procedure: Aim 1 Exercise Dosing;   Procedure: Aim 2 Control group
16 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
17 Recruiting Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: Myoblast transplantation;   Procedure: Saline injection
18 Recruiting A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: TAS-205;   Drug: Placebo
19 Recruiting Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Eplerenone;   Drug: Spironolactone
20 Recruiting Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
Condition: Duchenne Muscular Dystrophy
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.